Nervio
AI-based Surgical Neuromonitoring
StartupNervio is a startup in the Health Tech & Life Sciences sector, established in 2020. AI-based Surgical Neuromonitoring. The company has raised a total of $6.75M across 2 funding rounds, currently at the Seed stage. Nervio was founded by Omer Zarchi and Nir Zarchi. Key investors include Merchavia Holdings, eHealth Ventures. The company has 11-50 employees. Core technologies: Artificial Intelligence, Machine Learning.
With $6.75M in total funding, Nervio is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Beta.
- StageSeed
- ProductBeta
- ModelB2B
- Employees11-50
- HQMisgav, Israel
- Last Round$5.5M
- Merchavia Holdings
- eHealth Ventures
Omer ZarchiCo-Founder, CSONir ZarchiCo-founder, CPIO
2 articles covered by sources including www.calcalistech.com.
What does Nervio do?
Nervio is a digital health start-up applying data science and artificial intelligence in the field of neurophysiology. The company's mission is to prevent avoidable paralysis and severe neurologic complications during surgeries. Nervio's AI-powered neuromonitoring solution alerts clinicians in real time to any neurological complications right in the operating room, thus minimizing permanent nerve injuries.
How much funding has Nervio raised?
Nervio has raised $6.75M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include Merchavia Holdings, eHealth Ventures.
Who founded Nervio?
Nervio was founded in 2020 by Omer Zarchi (Co-Founder, CSO), Nir Zarchi (Co-founder, CPIO).
What sector is Nervio in?
Nervio operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, with core technologies in Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Nervio located?
Nervio is based in Misgav, Israel. The company also has offices abroad.